Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in sun pharma

Sun Pharma, Lupin Recall Products In US Market, Says USFDA

New Jersey-based Sun Pharmaceutical Industries Inc, a unit of the company, has initiated the Class III nationwide (US) recall of the 10-count blister packs on October 12 this year.

Read More

Sun Pharma Q2 Net Profit Rises 13% To Rs 2,047 Cr

The company had posted a net profit of Rs 1,812.79 crore for the corresponding period of the previous fiscal, Sun Pharma said in a regulatory filing.

Read More

Sun Pharma, Cassiopea Spa Ink License & Supply Agreements For Acne Treatment Drug Winlevi

The USFDA approved Winlevi (clascoterone cream 1 per cent) in August 2020, for the topical treatment of acne vulgaris in patients 12 years and older.

Read More

Sun Pharma Settles Patent Litigation With Celgene Corporation For Cancer Drug Revlimid

Shares of Sun Pharma were trading 0.19 per cent lower at Rs 669.95 apiece on BSE.

Read More

Dilip Shanghvi Resigns As MD Of SPARC

Prior to joining SPARC, Raghavan served as the managing director of the India and Sri Lanka business of Quintiles, a global pharmaceutical services company.

Read More

Lupin, Sun Pharma, Jubilant Cadista Recall Drugs In US Market

The affected lot has been produced by Jubilant Generics at its Roorkee based plant in Uttarakhand and marketed in the US by Salisbury-based Jubilant Cadista Pharmaceuticals, Inc.

Read More

Markets Eke Out Slim Gains In Choppy Trade; RBI Policy Eyed

Domestic equities were quite volatile and gave up most initial gains as sharp spike in COVID-19 cases across the country and resultant mobility restrictions continued to weigh on investors’ sentiments

Read More

Stock Mkts Start New Fiscal On A High; Sensex Reclaims 50,000-Level

Foreign investors offloaded equities worth Rs 1,685.91 crore in the Indian markets on Wednesday, exchange data showed.

Read More

Sun Pharma Q3 Net Profit Zooms Over 2-Fold To Rs 1,852 Cr

Consolidated total revenue from operations of the company stood at Rs 8,836.78 crore for the quarter under consideration.

Read More

Equity indices dip as traders book profit

Equity indices dip as traders book profit

Read More

Equity indices flat as banking, financial scrips shed gains

Equity indices flat as banking, financial scrips shed gains

Read More

IT, Pharma Stocks Lift Market Sentiment, HCL Tech Top Gainer

The BSE S&P Sensex closed 453 points or 0.99 per cent higher at 46,007 while the Nifty 50 edged up by 138 points or 1.03 per cent to 13,466.

Read More

Sun Pharma Q2 Net Profit Up 70% At Rs 1,813 Cr

The company had posted a net profit of Rs 1,064.09 crore for the corresponding period of the previous fisca

Read More

Sensex Crashes By 839 Points On Geopolitical Tensions, Bank Stocks Hit Badly

BSE S&P Sensex was down by 839 points or 2.13 per cent at 38,628 while the Nifty 50 lost by 305 points or 2.62 per cent at 11,342.

Read More

Equity Indices Remain Range-Bound, Tata Motors Top Gainer

The BSE S&P Sensex closed 45 points or 0.12 per cent at 38,844 while the Nifty 50 gained by 6 points or 0.05 per cent at 11,472.

Read More